Overview Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary This study assessed the bronchodilator efficacy of three different regimens of indacaterol in patients with asthma Phase: Phase 2 Details Lead Sponsor: Novartis Pharmaceuticals